Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
Clinical trial NCT03465592 · RECRUITING
Trial details
- NCT number
- NCT03465592
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-01
- Primary completion
- 2027-01-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.